Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Merck
Cipla
Express Scripts
Farmers Insurance
Healthtrust
Boehringer Ingelheim
Accenture
Chubb

Generated: June 24, 2018

DrugPatentWatch Database Preview

JADELLE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Jadelle patents expire, and when can generic versions of Jadelle launch?

Jadelle is a drug marketed by Population Council and is included in one NDA.

The generic ingredient in JADELLE is levonorgestrel. There are twenty drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.
Summary for JADELLE
Drug patent expirations by year for JADELLE
Medical Subject Heading (MeSH) Categories for JADELLE
Synonyms for JADELLE
(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one
(-)-17alpha-Ethynyl-18-methyl-19-nortestosterone
(-)-18,19-Dinor-13beta-ethyl-17beta-hydroxy-4-pregnen-20-yn-3-one
(-)-Levonorgestrel
(-)-Norgestrel
(-)-Norgestrel, 98%
(+-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one
(+-)-Norgestrel
(17?)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-yn-3-one
(1S,2R,10R,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxytetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one
(1S,2R,10R,11S,14R,15S)-15-ETHYL-14-ETHYNYL-14-HYDROXYTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-6-EN-5-ONE
(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one
(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one
(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-oxidanyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
[(-)-13-ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one
[18,(17.alpha.)-(-)-]
121714-72-5
13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE
13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one
13-Ehyl-17alpha-ethynyl-17-hydroxygon-4-en-3-one
13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one
13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one
13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one
13-Ethyl-17alpha-ethynyl-17-hydroxygon-4-en-3-one
13-ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one
13-Ethyl-17alpha-ethynylgon-4-en-17beta-ol-3-one
13-ethyl-17alpha-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one
13beta-Ethyl-17alpha-ethynyl-17 beta-hydroxygon-4-en-3-one
13beta-ethyl-17alpha-ethynyl-17-hydroxy-gon-4-en-3-one
13beta-ethyl-17alpha-ethynyl-17beta-hydroxy-gon-4-en-3-one
13beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one
17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one
17-alpha-Ethynyl-13-ethyl-19-nortestosterone
17-beta-Hydroxy-18-methyl-19-nor-17-alpha-pregn-4-en-20-yn-3-one
17-Ethynyl-18-methyl-19-nortestosterone
17alpha-Ethynyl-13-ethyl-19-nortestosterone
17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol
17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one
17alpha-ethynyl-17beta-hydroxy-18a-homoestr-4-en-3-one
17alpha-Ethynyl-18-homo-19-nor-testosterone
17alpha-Ethynyl-18-homo-19-nortestosterone
18-Methyl-17-alpha-ethynyl-19-nortestosterone
18-Methylnorethindrone
18-Methylnorethisterone
18,19-Dinor-13beta-ethyl-17 beta hydroxy-4-pregnen-20-yn-3-one
18,19-Dinor-13beta-ethyl-17beta-hydroxy-4-pregnen-20-yn-3-one
18,19-Dinor-17-alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-
18,19-Dinor-17-alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (+-)-
18,19-Dinor-17-alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (+)-
18,19-Dinor-4-pregnen-20-yn-3-one
18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(-)-
18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(+-)-
19-Nortestosterone, 17-ethynyl-18-methyl-
1lhv
4222-79-1
5W7SIA7YZW
6533-00-2
72-HOURS
797-62-6
797-63-7
797L637
A835065
AB0012485
AB2000252
AC1L211U
AC1Q6OEV
AJ-45701
AK161683
AKOS015894913
alpha-Norgestrel
BAY 86-5028
BAY86-5028
BCP9000852
BDBM50410522
BIDD:PXR0194
Bio-0595
BPBio1_000932
BRD-K35189033-001-03-0
BRN 2391114
BSPBio_000846
C08149
C08153
Capronor
CAS-797-63-7
CCG-100853
CCRIS 6525
CCRIS 9033
CHEBI:6443
CHEMBL1389
component of Lo/ovral
CS-2243
D-(-)-Norgestrel
D-Norgestrel
d(-)-Norgestrel
D(-)-Norgestrel, analytical standard
D00950
D00954
D0A9MR
D0BA9U
D0G6CT
DB00367
dl-13-beta-Ethyl-17-alpha-ethynyl-17-beta-hydroxygon-4-en-3-one
dl-13-beta-Ethyl-17-alpha-ethynyl-19-nortestosterone
dl-Norgestrel
DNorgestrel
DSSTox_CID_16496
DSSTox_GSID_36496
DSSTox_RID_79283
DTXSID3036496
E-Gen-C
EINECS 212-349-8
EINECS 229-433-5
EN300-122613
Fallback Solo
FH 122-A
Follistrel
FT-0658692
GTPL2881
HMS1570K08
HMS2051M08
HMS2090O06
HMS2097K08
HMS2232H06
HMS2232K12
HMS3649J10
HSDB 3595
HSDB 6483
HY-B0257
Kyleena
Ld norgestrel
LD norgestrel [French]
Levlen
Levlen ED
Levogel
Levonelle
Levonelle, D-Norgestrel, Levonova, Levonorgestrel
Levonelle;D-Norgestrel;Levonova
Levonorgestrel
Levonorgestrel (JAN/USP/INN)
Levonorgestrel (Levonelle)
Levonorgestrel [USAN:INN:BAN]
Levonorgestrel [USAN:USP:INN:BAN]
Levonorgestrel for system suitability 2, European Pharmacopoeia (EP) Reference Standard
Levonorgestrel implants
Levonorgestrel, European Pharmacopoeia (EP) Reference Standard
Levonorgestrel, pharmaceutical secondary standard; traceable to USP, PhEur, BP
Levonorgestrel, United States Pharmacopeia (USP) Reference Standard
Levonorgestrel(Levonelle)
Levonorgestrelum
Levonorgestrelum [INN-Latin]
Levonova
Levora-21
Levora-28
Levosert
Liletta
LMST02030119
LNG-IUS
LO/Ovral
Logynon ED
LS-62083
LS-62084
MCULE-1283162506
Methylnorethindrone
MFCD00199013
Microgest ED
Microgyn
Microgynon 21
Microgynon 28
Microgynon 30 ED
Microgynon CD
Microlut
Microlution
Microluton
Microval
Minivlar 30
Mirena
Mirena (TN)
MLS000069491
MLS000759484
MLS001074069
MLS001423967
MolPort-002-510-453
Monofeme 28
Monovar
N0889
NC00103
NCGC00159349-02
NCGC00159349-03
NCGC00159349-05
NCGC00257283-01
NCGC00260418-01
Neogest
Neogynon 21
Next choice
Nordet
Nordette
Nordette 21
Nordette 28
Norgeston
norgestrel
Norgestrel (JP15/USP/INN)
Norgestrel (JP17/USP/INN)
Norgestrel [Progestins]
Norgestrel [USAN:BAN:INN:JAN]
Norgestrel [USAN:INN:BAN:JAN]
Norgestrel [USAN:USP:INN:BAN:JAN]
Norgestrel-(-)-D
Norgestrelum
Norgestrelum [INN-Latin]
NorLevo
NORPLANT
Norplant (TN)
Norplant 2
Norplant II
Norplant System in Plastic Container
Norplant-2
NSC-744007
NSC744007
Opera_ID_552
Ovoplex 30-150
Ovral
Ovral-Lo
Ovranette
Ovrette
Ovrette (TN)
PL000229
Plan B
Plan B One Step
Plan B One-Step
Postinor
Postinor-2
Prestwick_109
Prestwick0_000773
Prestwick1_000773
Prestwick2_000773
Prestwick3_000773
Preven
Rigevidon 21+7
s1727
SCHEMBL27597
SH 70850
SH 850
Skyla
Skyla (TN)
SMR000059117
SMR000653526
SOH-075
SPBio_002785
SR-01000759218
SR-01000759218-5
SR-01000946725
SR-01000946725-1
Stediril 30
Tetragynon
Tox21_111593
Tox21_111593_1
Tox21_202872
Tox21_303658
Tri-Levlen
Tri-Levlen 21
Triagynon
Triciclor
Trifeme 28
Trigoa
Trinordiol 21
Trinordiol 28
Triphasil 21
Triphasil 28
Triquilar ED
Trivora
UNII-3J8Q1747Z2 component WWYNJERNGUHSAO-XUDSTZEESA-N
UNII-5W7SIA7YZW
WWYNJERNGUHSAO-XUDSTZEESA-N
Wy 3707
Wy-3707
Wy-5104
Z1551429747
ZINC3814395

US Patents and Regulatory Information for JADELLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Population Council JADELLE levonorgestrel IMPLANT;IMPLANTATION 020544-001 Nov 1, 1996 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
US Department of Justice
UBS
Julphar
Mallinckrodt
Argus Health
QuintilesIMS
Chinese Patent Office
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.